Download PDF
Thromb Haemost 1995; 74(04): 1113-1119
DOI: 10.1055/s-0038-1649890
Original Article
Coagulation
Schattauer GmbH Stuttgart

Orientation of the Carboxy-terminal Regions of Fibrin γ Chain Dimers Determined from the Crosslinked Products Formed in Mixtures of Fibrin, Fragment D, and Factor XIIIa

Kevin R Siebenlist
1   The University of Wisconsin Medical School Sinai Samaritan Medical Center, Milwaukee, WI, USA
2   The Department of Basic Health Sciences, School of Dentistry, Marquette University, Milwaukee, WI, USA
,
David A Meh
1   The University of Wisconsin Medical School Sinai Samaritan Medical Center, Milwaukee, WI, USA
,
Joseph S Wall
3   The Brookhaven National Laboratory, Biology Department, Upton, NY, USA
,
James F Hainfeld
3   The Brookhaven National Laboratory, Biology Department, Upton, NY, USA
,
Michael W Mosesson
1   The University of Wisconsin Medical School Sinai Samaritan Medical Center, Milwaukee, WI, USA
› Author Affiliations
Further Information

Publication History

Received 28 April 1995

Accepted after revision 05 July 1995

Publication Date:
09 July 2018 (online)

  PDF Download  Permissions and Reprints

Summary

There are two schools of thought regarding the orientation of the intermolecular ∈-amino-(γ-glutamyl) lysine isopeptide bonds formed between γ chains in the D domains of assembled fibrin fibers. Some investigators believe that these bonds are oriented parallel to the direction of fiber growth (longitudinally) at the contacting ends of fibrin D domains (‘DD-long’), whereas others believe that these bonds are oriented across the two-stranded fibril, between D domains in opposing strands (‘DD-transverse’). To distinguish between these two possibilities, the structure of crosslinked products formed in mixtures of fibrin, plasmic fragment D, and factor XIIIa were analyzed, based upon this rationale: Complex formation between D fragments and a fibrin template depends upon the non-covalent ‘D:E’ interaction between each fibrin E domain and two D fragments (‘D:fibrin:D’). If carboxy-terminal γ chains in the D:fibrin:D complex become aligned in a DD-long configuration, only crosslinked fragment D dimers (‘D-D’) will result and the fibrin ‘template’ will not become crosslinked to the associated D fragments. If instead, γ chain crosslinks form transversely between the D fragments and fibrin, covalently linked D-fibrin complexes will result.

SDS-PAGE of factor XIIIa crosslinked mixtures of fibrin and fragment D demonstrated products of a size and subunit composition indicating D-fibrin and D-fibrin-D formation. Small amounts of D dimers were also formed at the same levels as were formed in mixtures of fragment D and factor XIIIa alone. Electron microscopic images of D-fibrin-D complexes prepared under physiological buffer conditions demonstrated that the D fragments were associated with the central E domain of the fibrin molecule, but that they could be dissociated from this non-covalent association in 2% acetic acid. These findings indicate that γ chain crosslinks occur transversely in D:fibrin:D complexes and permit the extrapolated conclusion that γ chain crosslinks are also positioned transversely in an assembled fibrin polymer.

 

  • References

  • 1 Kudryck B, Reuterby J, Blombäck B. Adsorption of plasmic fragment D to thrombin modified fibrinogen-sepharose. Thromb Res 1973; 2: 297-304
    CrossrefPubMedGoogle Scholar
  • 2 Kudryck B, Collen D, Woods KR, Blombäck B. Evidence for localization of polymerization sites in fibrinogen. J Biol Chem 1974; 249: 3322-3325
    PubMedGoogle Scholar
  • 3 Kudryck B, Blombäck B, Blombäck M. Fibrinogen Detroit-An abnormal fibrinogen with non-functional NH2-terminal polymerization domain. Thromb Res 1976; 9: 25-36
    CrossrefPubMedGoogle Scholar
  • 4 Blombäck B, Hessel D, Hogg D, Therkildsen L. A two-step fibrinogen-fibrin transition in blood coagulation. Nature 1978; 275: 501-505
    CrossrefPubMedGoogle Scholar
  • 5 Budzynski AZ, Olexa SA, Pandya BV. Fibrin polymerization sites in fibrinogen and fibrin fragments. Ann NY Acad Sci 1983; 408: 301-314
    CrossrefPubMedGoogle Scholar
  • 6 Pisano JJ, Finlayson JS, Peyton MP. Crosslink in fibrin polymerized by factor XIII: ∈-(γ-glutamyl) lysine. Science 1968; 160: 892-893
    CrossrefPubMedGoogle Scholar
  • 7 Matačic S, Loewy AG. The identification of isopeptide crosslinks in insoluble fibrin. Biochem Biophys Res Comm 1968; 30: 356-362
    CrossrefPubMedGoogle Scholar
  • 8 McKee PA, Mattock P, Hill R. Subunit structure of human fibrinogen, soluble fibrin, and cross-linked insoluble fibrin. Proc Nat Acad Sci USA 1970; 66: 738-744
    CrossrefPubMedGoogle Scholar
  • 9 Folk JE, Finlayson JS. The ∈-(γ-glutamyl) lysine crosslink and the catalytic role of transglutaminases. Adv Prot Chem 1977; 31: 1-133
    PubMedGoogle Scholar
  • 10 Mosesson MW, Siebenlist KR, Amrani DL, DiOrio JP. Identification of covalently linked trimeric and tetrameric D domains in crosslinked fibrin. Proc Natl Acad Sci USA 1989; 86: 1113-1117
    CrossrefPubMedGoogle Scholar
  • 11 Shainoff JR, Urbanic DA, DiBello PM. Immunoelectrophoretic characterizations of the cross-linking of fibrinogen and fibrin by factor XIIIa and tissue transglutaminase. J Biol Chem 1991; 166: 6429-6437
    PubMedGoogle Scholar
  • 12 Grøn B, Filion-Myklebust C, Bjørnsen S, Haidaris P, Brosstad F. Cross- linked αsγt-chain hybrids in plasma clots studied by 1D- and 2D electrophoresis and western blotting. Thromb Haemost 1993; 70: 438-442
    Article in Thieme ConnectPubMedGoogle Scholar
  • 13 Siebenlist KR, Mosesson MW. Factors affecting γ-chain multimer formation in cross-linked fibrin. Biochemistry 1992; 31: 936-941
    CrossrefPubMedGoogle Scholar
  • 14 Chen R, Doolittle RF. Identification of the polypeptide chains involved in the cross-linking of fibrin. Proc Nat Acad Sci USA 1969; 63: 420-427
    CrossrefPubMedGoogle Scholar
  • 15 Chen R, Doolittle RF. γ-γ cross-linking sites in human and bovine fibrin. Biochemistry 1971; 10: 4486-4491
    CrossrefPubMedGoogle Scholar
  • 16 Doolittle RF, Chen R, Lau F. Hybrid fibrin: proof of the intermolecular nature of γ-γ crosslinking units. Biochem Biophys Res Comm 1971; 44: 94-100
    CrossrefPubMedGoogle Scholar
  • 17 Doolittle RF. Structural details of fibrin stabilization: implications for fibrinogen structure and initial fibrin formation. Thromb Diath Haemorrh 1973; 54 suppl 155-165
    PubMedGoogle Scholar
  • 18 Fowler WR, Hantgan R, Hermans J, Erickson H. Structure of the fibrin protofibril. Proc Nat Acad. Sci USA 1981; 78: 4872-4876
    CrossrefPubMedGoogle Scholar
  • 19 Fowler WE, Erickson HP, Hantgan RR, McDonagh J, Hermans J. Cross- linked fibrinogen dimers demonstrate a feature of the molecular packing in fibrin fibers. Science 1981; 211: 287-289
    CrossrefPubMedGoogle Scholar
  • 20 Erickson HP, Fowler WE. Electron microscopy of fibrinogen, its plasmic fragments and small polymers. Ann NY Acad Sci 1983; 408: 146-163
    CrossrefPubMedGoogle Scholar
  • 21 Weisel JW, Francis CW, Nagaswami C, Marder VJ. Determination of the topology of factor XIIIa-induced fibrin γ-chain cross-links by electron microscopy of ligated fragments. J Biol Chem 1993; 268: 26618-26624
    PubMedGoogle Scholar
  • 22 Selmayr E, Thiel W, Mϋller-Berghaus G. Crosslinking of fibrinogen to immobilized des AA-fibrin. Thromb Res 1985; 39: 459-465
    CrossrefPubMedGoogle Scholar
  • 23 Selmayr E, Bachmann L, Deffner M, Mϋller-Berghaus G. Chromatography and electron microscopy of cross-linked fibrin polymers-a new model describing the cross-linking at the DD-trans contact of the fibrin molecules. Biopolymers 1988 27: 1733-1748
    PubMedGoogle Scholar
  • 24 Mosesson MW, Siebenlist KR, Hainfeld JF, Wall JS. The structure of factor Xllla-crosslinked fibrinogen fibrils: evidence for double strands interlinked transversely through covalent bonds between carboxy-terminal regions of γchains. J Sir Biol. submitted
    PubMedGoogle Scholar
  • 25 Kazal LA, Amsel S, Miller OP, Tocantins LM. The preparation and some properties of fibrinogen precipitated from human plasma by glycine. Proc Soc Exp Biol Med 1963; 113: 989-994
    CrossrefPubMedGoogle Scholar
  • 26 Mosesson MW, Sherry S. The preparation and properties of human fibrinogen of relatively high solubility. Biochemistry 1966; 5: 2829-2835
    CrossrefPubMedGoogle Scholar
  • 27 Finlayson JS, Mosesson MW. Heterogeneity of human fibrinogen. Biochemistry 1963; 2: 42-46
    CrossrefPubMedGoogle Scholar
  • 28 Mosesson MW, Finlayson JS, Umfleet RA. Human fibrinogen heterogeneities III. Identification of γchain variants J Biol Chem 1972; 247: 5223-5227
    PubMedGoogle Scholar
  • 29 Galanakis DK, Mosesson MW, Stathakis NE. Human fibrinogen heterogeneities: distribution and charge characteristics of chains of Aケ origin. J Lab Clin Med 1978; 92: 376-386
    PubMedGoogle Scholar
  • 30 McFarlane AS. In vivo behavior of131l fibrinogen. J Clin Inv 1963; 42: 346-361
    CrossrefPubMedGoogle Scholar
  • 31 Belitser VA, Varetskaja TV, Malneva GV. Fibrinogen-fibrin interaction. Biochim Biophys Acta 1968; 154: 367-375
    CrossrefPubMedGoogle Scholar
  • 32 Mosesson MW, Finlayson JS. Subfractions of human fibrinogen-preparation and analysis. J Lab Clin Med 1963; 62: 663-674
    PubMedGoogle Scholar
  • 33 Lorand L, Gotoh T. Fibrinoligase. The fibrin stabilizing factor Methods Enzymol 1970; 19: 770-782
    PubMedGoogle Scholar
  • 34 Liewy AG, Dunathan K, Kriel R, Wolfinger HL, Fibrinase I. Purification of substrate and enzyme. J Biol Chem 1961; 236: 2625-2633
    PubMedGoogle Scholar
  • 35 Kanaide H, Shainoff JR. Cross-linking of fibrinogen and fibrin by fibrin-stabilizing factor (factor XIIIa). J Lab Clin Med 1975; 85: 574-597
    PubMedGoogle Scholar
  • 36 Robbins KC, Summaria L. Plasminogen and plasmin. Methods Enzymol 1976; 45: 257-273
    PubMedGoogle Scholar
  • 37 Robbins KC, Summaria L. Human plasminogen and plasmin. Methods Enzymol 1970; 19: 184-199
    PubMedGoogle Scholar
  • 38 Mosesson MW, Finlayson JS, Galanakis DK. The essential covalent structure of human fibrinogen evinced by analysis of derivatives formed during plasmic hydrolysis. J Biol Chem 1973; 248: 7913-7929
    PubMedGoogle Scholar
  • 39 Marder VJ, Budzynski AZ, James HL. High molecular weight derivatives of human fibrinogen produced by plasmin: (III) Their Nil,-terminal amino acids and comparison with the NH,-terminal disulfide knot. J Biol Chem 1972; 244: 2120-2124
    PubMedGoogle Scholar
  • 40 Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970; 227: 680-685
    CrossrefPubMedGoogle Scholar
  • 41 Mosesson MW, DiOrio JP, Siebenlist KR, Wall JS, Hainfeld JF. Evidence for a second type of fibril branch point in fibrin polymer networks, the trimolecular branch junction. Blood 1993; 82: 1517-1521
    CrossrefPubMedGoogle Scholar
  • 42 Mosesson MW, Hainfeld JF, Haschemeyer RH, Wall J. Identification and mass analysis of human fibrinogen molecules and their domains by scanning transmission electron microscopy. J Mol Biol 1981; 153: 695-718
    CrossrefPubMedGoogle Scholar
  • 43 Hainfeld JF, Wall JS, Desmond EJ. A small computer system for micrograph analysis. Ultramicroscopy 1982; 8: 263-270
    CrossrefPubMedGoogle Scholar
  • 44 Wall JS, Hainfeld JF. Mass mapping with the scanning transmission electron microscope. Ann Rev Biophys Chem 1986; 15: 355-376
    CrossrefPubMedGoogle Scholar
  • 45 Wall JS. Biological scanning transmission electron microscopy. In: Introduction to Analytical Electron Microscopy. Hren JJ, Goldstein JI, Joy DC. eds New York, NY: Plenum: 1979. pp 333-342
    CrossrefGoogle Scholar
  • 46 Wall JS. Limits on visibility of single heavy atoms in the scanning transmission electron microscope-anexperimental study. Chem Scripta 1979; 15: 271-278
    PubMedGoogle Scholar
  • 47 Weisel JW, Stauffacher CV, Bullitt E, Cohen C. A model for fibrinogen: domains and sequence. Science 1985; 230: 1388-1391
    CrossrefPubMedGoogle Scholar